William A. Fahy
GlaxoSmithKline (United Kingdom)(GB)Age UK(GB)National Jewish Health(US)Ernst & Young (United Kingdom)(GB)University of Colorado Denver(US)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms, Asthma and respiratory diseases, Inhalation and Respiratory Drug Delivery
Most-Cited Works
- → Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis(2019)329 cited
- → Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study(2017)296 cited
- → An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study(2017)269 cited
- → A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis(2019)142 cited
- → Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort(2019)139 cited
- → AZD9668, a neutrophil elastase inhibitor, plus ongoing budesonide/formoterol in patients with COPD(2011)85 cited